ArticleClinical and experimental medicine2025
Single-cell transcriptomics identifies SOCS3+ exhausted T cells as a biomarker facilitating clear cell renal cell carcinoma progression.
Article in Clinical and experimental medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Clear cell renal cell carcinoma (ccRCC), a prevalent renal malignancy with limited early symptoms, demonstrates immunotherapy sensitivity in advanced stages. This study investigates how exhausted T cells drive ccRCC progression through single-cell transcriptomics. Re-analysis of a single-cell transcriptomic dataset was performed through dimensionality reduction and clustering to annotate cells into distinct populations, followed by comprehensive characterization of cellular composition and subset-specific features. Prognostically relevant genes were identified via differential gene expression (DGE) analysis, and a nomogram prediction model was constructed using Cox regression analysis, with validation through Kaplan-Meier (KM) survival curves and risk score plots. Functional annotation of SOCS3+ exhausted T cells was achieved via gene ontology (GO) and reactome pathway enrichment analyses. Cell-cell communication networks involving SOCS3+ exhausted T cells were delineated using ligand-receptor interaction profiling. Single-cell transcriptomic data were annotated into nine distinct cellular populations, among which SOCS3+ exhausted T cells demonstrated significant prognostic relevance. A nomogram prediction model incorporating SOCS3 and N4BP1 effectively stratified patients into low- and high-risk groups with superior prognostic predictive power compared to conventional parameters. Cell-cell communication analysis revealed that SOCS3+ exhausted T cells interact with myeloid cells through the MIF signaling pathway. Integrated single-cell transcriptomic analysis demonstrates that SOCS3+ exhausted T cells promote tumor resistance to cytotoxic killing and serve as a robust prognostic biomarker in ccRCC patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.